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B R I E F R E P O RT

Cephalalgiaphobia: a possible specific phobia
of illness

Abstract Psychiatric comorbidity,
mainly anxiety and depression, are
common in chronic migraine (CM).
Phobias are reported by half of CM
patients. Phobic avoidance associated with fear of headache or
migraine attack has never been adequately described. We describe 12
migraine patients with particular
phobic-avoidant behaviours related
to their headache attacks, which we
classified as a specific illness
phobia, coined as cephalalgiaphobia. All patients were women, mean
age 42, and all had a migraine diagnosis (11 CM, all overused acute
medications). Patients had either a
phobia of a headache attack during
a pain-free state or a phobia of pain
worsening during mild headache
episodes. Patients overused acute
medication as phobic avoidance. It
is a significant problem, associated
with distress and impairment, interfering with medical care.

Introduction
Psychiatric comorbidity is common among chronic migraine
(CM) patients [1]. Anxiety and mood disorders are the most
important conditions in CM, affecting up to 85% of patients

Cephalalgiaphobia is a possible
specific phobia of illness, possibly
linked to progression of migraine to
CM and to acute medication
overuse headache.

Keywords Phobia • Migraine •
Anxiety disorders • Illness phobia
Comorbidity

•

[2–4], causing significant decrease in their quality of life [5].
Anxiety disorders were found in 76% of CM patients, generalised anxiety disorder (GAD) in 52%, and phobias in 54% [6,
7]. Social phobia is three-fold more common in migraineurs
than in controls [8]. Phobias and migraines were linked
genetically via the DRD2 dopamine receptor allele [9].
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Specific phobia of illness appears in the DSM-IV [10]
under the heading of specific phobias as a new subtype of specific phobia, separate from hypochondriasis. Illness phobia is
a major problem, common in the general population, associated with distress and impairment, interfering with medical
care [11]. Patients fear contracting a condition seen as lifethreatening, such as cancer, heart disease or AIDS. Patients
experiencing aversive symptoms, such as shortness of breath
in lung diseases or chest pain in a coronary artery disorder
may fear their reoccurrence [12]. A migraine attack can also
be a very aversive experience, and the migraineur easily fears
another severe attack. Nevertheless, phobia of a headache or
migraine attack has never been adequately described.

Methods
We report 12 patients followed at a tertiary headache clinic in a hospital in São Paulo, Brazil. It has come to our attention that for individuals presenting a particular avoidance behaviour related to their
headache attacks, the idea that a specific phobia of headache was an
important issue in their clinical picture and management. We therefore
started to pay special attention to those patients after June 2005. The
estimated prevalence rate of cephalalgiaphobia in the CM population
at our headache center in 60%. Although the number of patients was
small, we found this pattern in the majority of CM patients. Patients
were diagnosed according to SCID-IV [10] and ICHD-II [13]. All met
diagnostic criteria for a specific phobia based on DSM-IV (Table 1).

Results
All patients were women, mean age 42.6±9.8 years
(range 26–59). All patients had a migraine diagnosis; 11

had CM. All patients overused acute medications.
Patients also fit Silberstein and Lipton’s 1996 transformed migraine diagnostic criteria [14, 15]. Patients
presented either anticipatory anxiety, fearing a headache
attack during a pain-free period, or fearing that pain
would worsen during a period of mild headache. As
avoidance behaviour, patients overused acute medications despite being aware that it was the fear of having
another migraine attack or a headache exacerbation that
made them take more analgesics than necessary. The
sedation-seeking behaviour, “soporophilia”, described
by Saper et al. [16] was not identified. The fear of a
headache attack or exacerbation was marked and persistent. It was considered excessive but not always unreasonable, because previous severe headaches experienced
with intense suffering was the specific object of anticipation. Exposure to the phobic stimulus could be the
baseline headache, or might not occur. A headache-free
state with intense anxious anticipation or distress could
elicit the phobic behaviour and the overuse of acute
medications, interfering with patients’ regular activities.
As is common in mental disorders, most patients also
met criteria for psychiatric conditions other than cephalalgiaphobia (Table 2).

Discussion
Phobias and migraine are related in several ways. Genetic,
epidemiologic and clinical data confirm this association
[6–9]. Cephalalgiaphobia can be possibly classified as an
anxiety disorder, under the heading of specific phobias,
different from other specific phobias. It may also be subdivided into other subtypes such as phobia of existing

Table 1 Diagnostic criteria for specific phobia according to the DSM-IV
A. Marked and persistent fear that is excessive or unreasonable, cued by the presence or anticipation of a specific object or situation
(e.g., flying, heights, animals, receiving an injection, seeing blood).
B. Exposure to the phobic stimulus almost invariably provokes an immediate anxiety response, which may take the form
of a situationally bound or situationally predisposed panic attack. Note: In children, the anxiety may be expressed by crying,
tantrums, freezing or clinging.
C. The person recognises that the fear is excessive or unreasonable. Note: In children, this feature may be absent.
D. The phobic situation(s) is avoided or else is endured with intense anxiety or distress.
E. The avoidance, anxious anticipation or distress in the feared situation(s) interferes significantly with the person’s normal routine,
occupational (or academic) functioning, or social activities or relationships, or there is marked distress about having the phobia.
F. In individuals under age 18 years, the duration is at least 6 months.
G. The anxiety, panic attacks or phobic avoidance associated with the specific object or situation are not better accounted
for by another mental disorder, such as obsessive–compulsive disorder (e.g., fear of dirt in someone with an obsession about
contamination), post-traumatic stress disorder (e.g., avoidance of stimuli associated with a severe stressor), separation anxiety
disorder (e.g., avoidance of school), social phobia (e.g., avoidance of social situations because of fear of embarrassment),
panic disorder with agoraphobia, or agoraphobia without history of panic disorder.
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Table 2 Age, gender, headache diagnosis, acute medication overuse and psychiatric diagnosis of cephalalgiaphobia patients
Patient

Gender

Age

Headache diagnosis

Acute medication overuse (n. per week)

Other psychiatric diagnosis

1

F

42

CM

Erg (14), analgesic (7)

Panic disorder, MDD, GAD

2

F

32

MAM

–

GAD, agora

3

F

38

CM

Sumatriptan (7)

MDD, phobia

4

F

53

CM

Analgesic (7), nsaid (7)

Panic MDD, GAD

5

F

26

CM

Nsaid (4)

Phobia, GAD, BDII

6

F

52

CM

Analgesic (14), Erg (14)

BDII, GAD

7

F

59

CM

Nsaid (7), sumatriptan (7), opioid (7)

MDD, GAD

8

F

49

CM

Analgesic (21)

MDD, phobia

9

F

41

CM

Naratriptan (7), analgesic (14)

MDD, phobia, GAD

10

F

40

CM

Analgesic (21)

MDD, GAD, anorexia, phobia

11

F

48

CM

Rizatriptan (5)

MDD, GAD, phobia

12

F

39

CM

Analgesic (14), naratriptan (7)

BDII, GAD

CM, chronic migraine; MAM, menstrually associated migraine; erg, ergotamine; nsaid, nonsteroidal antiinflamatory; MDD, major depressive disorder; BDII, bipolar disorder type II; GAD, generalised anxiety disorder

medical illness. A possible new subtype of specific phobia, cephalalgiaphobia is widening the range of psychiatric comorbidity in headache disorders.
Fears are divided into four consistent factors: fear of
bodily harm (death, injury, illness, blood and surgical procedures), animal fears, interpersonal fears and agoraphobic fears. Cephalalgiaphobia, although classified as a phobia of illness under specific phobia, other type, can be
considered a bodily-harm type of phobia. Marks classified
abnormal illness fears among the phobias of internal stimuli. He noted that they are intense fears of specific conditions, such as cancer or heart disease, and distinguished
them from hypochondriasis, in which diffuse fear is
focused on multiple symptoms rather than a particular illness [17]. Another illness phobia frequently observed in
headache care is the phobia of having a brain tumour or
aneurysm. Our patients did not present hypochondriasis;
although MMPI scores regarding this aspect are elevated
in CM [18], we did not use these in our sample. The
instrument may not be as accurate for psychiatric diagnosis as the DSM-IV.
Fears of illness are common in the general population. In
Burlington, Vermont, some degree of illness fear was found
in 18.2% of the population [19]. Phobic disorders are
comorbid with other psychiatric conditions, particularly
anxiety disorders [20]. There is also an increasing risk of the
patient developing depression and substance abuse disorder
[21]. Cephalalgiaphobia might be inserted into the same
context of psychiatric comorbidity previously found in CM.

Fear of having an attack or of worsening of a baseline headache may be the underlying mechanism behind
the excessive acute medication intake often seen in CM
and chronic daily headache. Cephalalgiaphobia may
decrease the threshold for initiating the analgesic consumption behaviour, leading to acute medication
overuse. MOH pathophysiology may be linked to this
mechanism. Saper et al. [16] have identified the “biobehavioural” aspect of MOH. Anticipatory anxiety, obsessional drug-taking behaviours and drug dependence
were considered important.
Bouton et al. [22] suggested a model of fear conditioning for panic disorder that we believe fits our hypothesis on the development of cephalalgiaphobia. The exposure to headache, an internal unconditioned aversive stimuli, would cause a conditioning of anxiety to exteroceptive and interoceptive cues.
Health care behaviour and cost may be influenced.
Fears and phobias interfere with medical care [23–25].
The cost for a migraine patient with anxiety was US$
12 642 vs. US$5179 in those without it [26]. Some people
delay seeking medical attention, potentially affecting their
outcome [27].
Cephalalgiaphobia may open therapeutic windows in
the treatment of CM patients; therapy with standard medications or treatments for phobias could be needed in this
context. Tricyclic antidepressants, SSRIs, benzodiazepines, GABAergic compounds and psychotherapy may
be indicated.
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